Valine

Valine

SCHEMBL3055733

CC(C)[C@H](N)C(=O)O.CC(C)[C@H](N)C(=O)O.C[C@H](N)C(=O)O.N[C@@H](CS)C(=O)O.O=C(O)[C@@H]1CCCN1

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

SLC5A2

The experimentally established mechanism targets of Valine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 1/20 0.40
SLC7A11 Q9UPY5 1/20 0.40
SLC7A5 Q01650 1/20 0.38
CPN1 P15169 2/20 0.33
CPB2 Q96IY4 2/20 0.33
PRCP P42785 1/20 0.31
DPP7 Q9UHL4 1/20 0.30
NOS2 P35228 2/20 0.30
NOS3 P29474 1/20 0.30
NOS1 P29475 1/20 0.30
MEN1 O00255 1/20 0.30
ALDH1A1 P00352 1/20 0.30
CYP1A2 P05177 1/20 0.30
THRB P10828 1/20 0.30
ALOX15 P16050 1/20 0.30
CYP2C19 P33261 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Valine SCHEMBL3054588 0.99 PTGS1 (0.39) PTGS1SLC7A11SLC7A5CPN1CPB2
Valine SCHEMBL7646500 0.97 PTGS1 (0.42) PTGS1SLC7A11SLC7A5CPN1CPB2
Valine SCHEMBL28182158 0.97 PTGS1 (0.42) PTGS1SLC7A11SLC7A5CPN1CPB2
Valine SCHEMBL28182157 0.97 PTGS1 (0.42) PTGS1SLC7A11SLC7A5CPN1CPB2
Valine SCHEMBL27660752 0.97 PTGS1 (0.42) PTGS1SLC7A11SLC7A5CPN1CPB2
Valine SCHEMBL5666087 0.95 PTGS1 (0.36) PTGS1SLC7A11SLC7A5CPN1CPB2
Valine SCHEMBL28189265 0.95 PTGS1 (0.36) PTGS1SLC7A11SLC7A5CPN1CPB2
Valine SCHEMBL6368984 0.94 PTGS1 (0.36) PTGS1SLC7A11SLC7A5
Proline SCHEMBL7204958 0.94 PTGS1 (0.46) PTGS1SLC7A11CPN1CPB2PRCP
Asparagine SCHEMBL5665078 0.93 PTGS1 (0.35) PTGS1SLC7A11SLC7A5CPN1CPB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7666842-B2 Elastin peptide analogs and uses thereof Connective Tissue Imagineering, LLC (US) 2010-02-23 US disclosed
US-20050054578-A1 Elastin peptide analogs and uses thereof SANDBERG LAWRENCE B (US) 2005-03-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050054578-A1 Elastin peptide analogs and uses thereof ELANE, CUTA, ENPEP PTGS1 1903/4885SLC7A11 3769/4885SLC7A5 2652/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.